AMYOTROPHIC LATERAL SCLEROSIS : A REVIEW
International Journal of Medicine & Health Research (IJMHR) (ISSN 2395-3586) · 26.12.2024 · 12
DOI: 10.71393/5e8v8h62 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medicine & Health Research (IJMHR) (ISSN 2395-3586), online erschienen am 26.12.2024. Verfasst von Mukesh Bansal und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) also called Lou Gehrig's disease is a rapidly progressive, invariably fatal neurologicaldisease that attacks the nerve cells (neurons) that responsible for controlling voluntary muscles.several known ALS geneswere fund to be associated and TBK1 (the gene encoding TANK binding kinase) was identified as an ALS gene. In theUnited States, more than 5,600 are diagnosed every year, and up to 30,000 Americans are currently affected. ALS isresponsible for two deaths per 100,000 people per year. Smoking, Lead exposure & Heredity are the major factor for ALS.No cure has yet been found for ALS. However, the Food and Drug Administration (FDA) approved the first drug i.e.riluzole (Rilutek)—in 1995. Riluzole is believed to reduce damage to motor neurons by decreasing the release of glutamate.However, new medications or combinations of drugs would be beneficial for cure or prevention of diaease.
Zitieren
APA
Bansal, M., Singhvi, I., & Rajpurohit, R. (2024). AMYOTROPHIC LATERAL SCLEROSIS : A REVIEW. International Journal of Medicine & Health Research (IJMHR) (ISSN 2395-3586), 12. https://doi.org/10.71393/5e8v8h62
Vancouver
Bansal M, Singhvi I, Rajpurohit R. AMYOTROPHIC LATERAL SCLEROSIS : A REVIEW. International Journal of Medicine & Health Research (IJMHR) (ISSN 2395-3586). 2024;12. doi:10.71393/5e8v8h62
BibTeX
@article{Bansal2024,
author = {Bansal, Mukesh and Singhvi, I.J. and Rajpurohit, Rahul},
title = {AMYOTROPHIC LATERAL SCLEROSIS : A REVIEW},
journal = {International Journal of Medicine & Health Research (IJMHR) (ISSN 2395-3586)},
year = {2024},
volume = {12},
doi = {10.71393/5e8v8h62}
}
EUVIMED